Exploring Integrin α5β1 as a Potential Therapeutic Target for Pulmonary Arterial Hypertension: Insights from Comprehensive Multicenter Preclinical Studies

Sarah‐Eve Lemay(SNC-Lavalin (Canada)), Sébastien Bonnet(Institut universitaire de cardiologie et de pneumologie de Québec), Terence I. Moy(Maine Farmland Trust), Qi Qiao(Jilin University), Hua Wang(Maine Farmland Trust), Adrian S. Ray(Maine Farmland Trust), Bryan Goodwin(Maine Farmland Trust), François Potus(Queen's University), James J. Dowling(Maine Farmland Trust), Yann Grobs(Institut universitaire de cardiologie et de pneumologie de Québec), Sandra Martineau(Canadian Heart Research Centre), Tetsuro Yokokawa(Fukushima Medical University), Steeve Provencher(Institut universitaire de cardiologie et de pneumologie de Québec), Charlotte Romanet(Canadian Heart Research Centre), Tsukasa Shimauchi(Kyushu University), Olivier Boucherat(Lung Institute), Sandra Breuils‐Bonnet, Mélanie Sauvaget(Canadian Heart Research Centre), Reem El Kabbout(Canadian Heart Research Centre), Charlie Théberge(Canadian Heart Research Centre), T. Andrew McTeague(Maine Farmland Trust), Min Lü(Central South University), Keiko Yamamoto(Hesco (United States)), Fu‐Yang Lin(Maine Farmland Trust), Andréanne Pelletier(Canadian Heart Research Centre), Blaise Lippa(Maine Farmland Trust), Alice Bourgeois, Mónica S. Montesinos(Universidad de La Laguna)
bioRxiv (Cold Spring Harbor Laboratory)
June 1, 2024
Cited by 0


Related Papers